VAN ECK ASSOCIATES CORP - CUBIST PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of CUBIST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$16,970,000
+55.6%
168,606
+2.6%
0.11%
+82.8%
Q3 2014$10,903,000
-6.1%
164,352
-1.2%
0.06%
+7.4%
Q2 2014$11,611,000
-18.5%
166,302
-14.6%
0.05%
-23.9%
Q1 2014$14,242,000
+3.8%
194,702
-2.2%
0.07%
+2.9%
Q4 2013$13,715,000
+37.7%
199,141
+27.1%
0.07%
+35.3%
Q3 2013$9,958,000
+33.0%
156,694
+1.1%
0.05%
+24.4%
Q2 2013$7,488,000155,0560.04%
Other shareholders
CUBIST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 1,843,688$122,310,0009.14%
HealthCor Management, L.P. 1,100,000$72,974,0003.75%
SECTOR GAMMA AS 199,990$13,267,0003.10%
AMI ASSET MANAGEMENT CORP 365,309$24,235,0002.38%
Redmile Group, LLC 283,756$18,824,0002.17%
EAGLE BOSTON INVESTMENT MANAGEMENT INC 1,134,336$75,250,0002.10%
PointState Capital LP 1,650,000$109,461,0001.98%
Tamarack Capital Management, LLC 110,000$7,297,0001.62%
Tekla Capital Management LLC 494,454$32,802,0001.54%
WESTFIELD CAPITAL MANAGEMENT CO LP 3,421,430$226,978,0001.39%
View complete list of CUBIST PHARMACEUTICALS INC shareholders